Telix Pharmaceuticals Limited

TLX ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements SEC Filings

SEC Filings

Form Filed Description
3 Apr 1, 2026 FORM 3
3 Apr 1, 2026 FORM 3
20-F/A Mar 20, 2026 20-F/A
3 Mar 18, 2026 FORM 3
3 Mar 18, 2026 FORM 3
3 Mar 18, 2026 FORM 3
6-K Mar 16, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Mar 10, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
F-3ASR Feb 20, 2026 F-3ASR
20-F Feb 20, 2026 20-F
6-K Feb 19, 2026 6-K
6-K Feb 18, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Feb 3, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Jan 20, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Jan 12, 2026 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Dec 22, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Dec 17, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Dec 8, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Oct 14, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Sep 23, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Sep 9, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Aug 28, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Aug 21, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Jul 22, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Jul 9, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
← Newer Page 2 of 5 · 102 filings Older →